AAWH (Ascend Wellness Holdings) Return-on-Tangible-Equity: 0.00% (As of Mar. 2026)


AAWH Ascend Wellness Holdings Inc AAWH
44 GF Score
Price $0.47
GF Value $0.73
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Ascend Wellness Holdings Return-on-Tangible-Equity?

Ascend Wellness Holdings AAWH -5.74% 44 Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus rates AAWH with a GF Score™ of 44/100 and a GF Value™ of $0.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 898 Drug Manufacturers companies, Ascend Wellness Holdings ranks worse than 111358.46% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Ascend Wellness Holdings's annualized net income for the quarter that ended in Mar. 2026 was $-118.0 Mil. Ascend Wellness Holdings's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $-313.2 Mil. Therefore, Ascend Wellness Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was N/A%.

The historical rank and industry rank for Ascend Wellness Holdings's Return-on-Tangible-Equity or its related term are showing as below:

AAWH's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.88
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Ascend Wellness Holdings  (OTCPK:AAWH) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Ascend Wellness Holdings Return-on-Tangible-Equity Related Terms


Ascend Wellness Holdings Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Ascend Wellness Holdings's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascend Wellness Holdings Return-on-Tangible-Equity Chart

Ascend Wellness Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Equity
Get a 7-Day Free Trial -5,147.17 0.00 0.00 0.00 0.00

Ascend Wellness Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AAWH vs ZTS, UTHR: Return-on-Tangible-Equity Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ascend Wellness Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascend Wellness Holdings Return-on-Tangible-Equity vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascend Wellness Holdings's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Ascend Wellness Holdings's Return-on-Tangible-Equity falls into.


AAWH
44GF Score
Ascend Wellness Holdings Inc AAWH
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascend Wellness Holdings Return-on-Tangible-Equity Calculation

Ascend Wellness Holdings's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-118.193/( (-184.123+-301.965 )/ 2 )
=-118.193/-243.044
=N/A %

Ascend Wellness Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-117.972/( (-301.965+-324.442)/ 2 )
=-117.972/-313.2035
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Ascend Wellness Holdings (AAWH) has a Return-on-Tangible-Equity of 0.00% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ascend Wellness Holdings and its competitors. According to the industry distribution chart, Ascend Wellness Holdings ranks #999999 out of 898 companies in the Drug Manufacturers industry.
Is Ascend Wellness Holdings' Return-on-Tangible-Equity too high?
Ascend Wellness Holdings' current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Ascend Wellness Holdings ranks #999999 out of 898 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ascend Wellness Holdings has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ascend Wellness Holdings' Return-on-Tangible-Equity compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ascend Wellness Holdings ranks #999999 out of 898 companies for Return-on-Tangible-Equity. This places Ascend Wellness Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.88, based on 898 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ascend Wellness Holdings and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascend Wellness Holdings's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascend Wellness Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ascend Wellness Holdings (AAWH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.73, compared to a current price of $0.47 — trading 35.4% below its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Ascend Wellness Holdings' overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Ascend Wellness Holdings (AAWH), the current Return-on-Tangible-Equity is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ascend Wellness Holdings (AAWH) Overvalued in 2026?

Based on GuruFocus' analysis, Ascend Wellness Holdings stock appears to be undervalued. The current stock price of $0.47 is trading 35.4% below its estimated GF Value™ of $0.73. GuruFocus considers Ascend Wellness Holdings to be Possible Value Trap.

Key valuation signals for AAWH:

  • Return-on-Tangible-Equity: 0.00%
  • GF Value™: $0.73 vs. price of $0.47 (35.4% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the AAWH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ascend Wellness Holdings Business Description

Other Exchanges 8VJ:GermanyAAWH.U:Canada
Address Rochelle Park, Morristown, NJ, USA, 07662
Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited licenses markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.
44GF Score

Get the complete analysis for AAWH

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.47
Price
$0.73
GF Value